Unichem Laboratories lost 8.85% to Rs 202.50 at 10:21 IST on BSE, after net profit declined 38.4% to Rs 22.32 crore on 3.3% rise in net sales to Rs 274.95 crore in Q2 September 2014 over Q2 September 2013.
The company announced Q2 results on Saturday, 18 October 2014.
Meanwhile, the S&P BSE Sensex was up 329.14 points or 1.26% at 26,437.67
On BSE, so far 40,009 shares were traded in the counter as against average daily volume of 28,641 shares in the past one quarter.
The stock hit a high of Rs 220 and a low of Rs 196.05 so far during the day. The stock had hit a 52-week low of Rs 161.10 on 18 October 2013. The stock had hit a 52-week high of Rs 254.45 on 11 September 2014.
The stock had outperformed the market over the past one month till 17 October 2014, falling 0.65% compared with Sensex's 1.96% fall. The scrip had also outperformed the market in past one quarter, rising 13.54% as against Sensex's 2.14% rise.
The small-cap pharmaceutical company has equity capital of Rs 18.14 crore. Face value per share is Rs 2.
Unichem Laboratories is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world.
Powered by Capital Market - Live News
